Fundraising FoxViking Global Investors — 2023 Investments
8 investments dated 2023 · listed companies and verified rows first · show all
Allonnia applies industrial biology—screening microbes and engineered proteins that interact with metals—to recover copper, nickel, and rare earths from ore and mine waste streams like coal ash, tailings, and acid mine drainage.
BiotechCleantechNew MaterialsBoston, US
Nicole Richards(CEO)inKent Sorenson(Chief Technology Officer)inChuck(Executive)inPamela(Head of Human Resources)inHugh(Financial Leadership)in
BoardTom Biegala(Director)in
Co-investorsBison VenturesGeneral AtlanticViking GlobalBHP VenturesFerment StudioVale Ventures
Ecovative grows whole-cut meat alternatives and leather-like materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Eben Bayer(Cofounder)inGavin McIntyre(Founder)in
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout LabsBreakout VenturesCool Climate CollectiveStray Dog CapitalTrousdale VenturesViking Global+3 more
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+10 more
Keboola provides a data platform that helps organizations turn data into reliable decisions.
AI & Machine LearningClimate TechCloud ComputingData & InfrastructureFintechSaaS
Petr Simecek(Founder)inMarek Streibl(Founder)Milan Vesely(Founder)
Co-investorsPresto VenturesReflex CapitalViking GlobalTCF Capital
.jpg)
Latitude Health builds AI-driven technology for utilization management (UM), including intake and triage, clinical review, and performance insights, designed with UM leaders and clinicians.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Chuck Feerick(Founder)inGuru Nadiger(Founder)inJarred Bressner(Director)Chris Palmieri(Director)
Co-investorsAlleyCorp
San Francisco, US
Catherine Planey(Executive Officer, Director)Alexander Mok(Executive Officer, Director)
BoardFrancisco Gimenez(Director)in
Co-investorsBoxGroupGaingelsMana VenturesNat Turner8VCAllen & Company+1 more
__Twitter.png)
Computational microbiome analysis platform for immunologic disorders
Kareem Barghouti(Founder)inMohamed Donia(Founder)in
Co-investors3CC | Third Culture CapitalGood AI CapitalHarmonix FundIaso VenturesJoyance PartnersMerck Global Health Innovation Fund+5 more
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia.
BiotechHealthtechWellness & FitnessWaltham, US
ILISSA LARIMORE(Executive Officer)inGERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)
BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)inNEAL BHADKAMKAR(Director)in
Co-investorsJoyance PartnersOlive Tree CapitalRising TideBold Capital PartnersDigitalDx VenturesGISEV Family Office+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.